New concepts in bilirubin encephalopathy

European Journal of Clinical Investigation

Volumn 33, Issue 11, 2003, Pages 988-997

  Ostrow, J D ^a,d   Pascolo, L ^b   Shapiro, S M ^c   Tiribelli, C ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Research Service (151L)   (United States)

Author keywords

Bilirubin; Encephalopathy; Jaundice; Kernicterus; Neonates; Nuerotoxicity

Indexed keywords

ABC TRANSPORTER; ALBUMIN; BILIRUBIN; CARBROMAL; GLUTATHIONE TRANSFERASE; NEUROTRANSMITTER; ORGANIC ANION TRANSPORTER; WATER;

ALBUMIN BLOOD LEVEL; ANION TRANSPORT; APOPTOSIS; ASTROCYTE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BINDING AFFINITY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CAPILLARY; BRAIN MITOCHONDRION; CAPILLARY ENDOTHELIUM; CELL DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CYTOSOL; DIFFUSION; DISEASE PREDISPOSITION; ENERGY METABOLISM; HUMAN; KERNICTERUS; MEMBRANE TRANSPORT; NERVE CELL CULTURE; NERVE CELL MEMBRANE; NEUROTOXICITY; NONHUMAN; OXIDATION; PASSIVE TRANSPORT; PATHOPHYSIOLOGY; PH; PRECIPITATION; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTON TRANSPORT; REVIEW; SOLUBILITY;

ANIMALS; BILIRUBIN; BLOOD-BRAIN BARRIER; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; RATS; RATS, GUNN;

EID: 0242552895     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01261.x     Document Type: Review

References (149)

1. Gourley GR. Bilirubin metabolism and kernicterus. Adv Pediatr 1997;44:173-229.
2. Pascolo L, Fernetti C, Crivellato E, Garcia-Mediavilla MV, Ostrow JD, Tiribelli C. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 2001;495:94-9.
3. Serrano MA, Bayón JE, Pascolo L, Tiribelli C, Ostrow JD, Gonzalez-Gallego J et al. Evidence for carrier-mediated transport of unconjugated bilirubin across plasma membrane vesicles from human placental trophoblast. Placenta 2002;23:527-35.
4. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinaemia. N Engl J Med 2001;344:581-90.
5. Midtvedt AC, Carlstedt-Duke B, Norin KE, Saxerholt H, Midtvedt T. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Pediatr Gastroenterol Nutr 1988;7:559-67.
6. Vítek L, Kotal P, Jirsa M, Malina J, Cerna M, Chmelar D et al. Intestinal colonization leading to fecal urobilinoid excretion may play a role in the pathogenesis of neonatal jaundice. J Pediatr Gastroenterol Nutr 2000;30:294-8.
7. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: iliverdin and bilirubin. Meth Enzymol 1990;186:301-9.
8. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999;96:2445-50.
9. Dore S, Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 1999;890:167-72.
10. Schneider AP. Breast milk jaundice in the newborn. A real entity. JAMA 1986;255:3270-4.
11. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinaemia. Proc Natl Acad Sci USA 1997;94:12128-32.
12. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ et al. Prediction of hyperbilirubinaemia in near-term and term infants. J Perinatol 2001;21 (Suppl. 1):S63-S72.
13. Saigal S, Lunyk O, Bennett KJ, Patterson MC. Serum bilirubin levels in breast-and formula-fed infants in the first 5 days of life. Can Med Assoc J 1982;127:985-9.
14. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96:730-3.
15. Kadakol A, Sappal BS, Ghosh SS, Lowenheim M, Chowdhury A, Chowdhury S et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet 2001;38:244-9.
16. Monaghan G, McLellan A, McGeehan A, Li VS, Mollica F, Salemi I et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinaemia of the newborn. J Pediatr 1999;134:441-6.
17. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinaemia. Gastroenterology 2002;123:127-33.
18. Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 1981;196:257-60.
19. Vohr BR, Karp D, O'Dea C, Darrow D, Coll CG, Lester BM et al. Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinaemia [see comments]. J Pediatr 1990;117:288-91.
20. Wennberg RP. The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol 2000;20:97-109.
21. Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol 1990;17:371-9.
22. Volpe JJ. Bilirubin and brain injury. In: Volpe JJ, editor. Neurology and the Newborn. Philadelphia: W.B. Saunders;1995.pp. 490-514.
23. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin N Am 1960;7:665-87.
24. Larroche JC. Kernicterus. In: Bruyn VP, Bruyn GW, editors. Handbook of Clinical Neurology. Amsterdam: North-Holland; 1968.pp. 491-515.
25. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatrician's nemesis. Clin Perinatol 1998;25:295-302.
26. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002;140:396-403.
27. Hansen TW. Kernicterus in term and near-term infants - the specter walks again. Acta Paediatr 2000;89:1155-7.
28. Brodersen R. Binding of bilirubin to albumin; implications for prevention of bilirubin encephalopathy in the newborn. CRC Crit Rev Clin Lab Sci 1979;11:305-99.
29. Weisiger RA. The role of albumin binding in hepatic organic anion transport. In: Tavoloni N, Berk PD, editors. Hepatic Transport and Bile Secretion; Physiology and Pathphysiology. New York: Raven Press;1993.pp. 171-96.
30. Ahlfors CE. Bilirubin-albumin binding and free bilirubin. J Perinatol 2001;21 (Suppl. 1):S40-S42.
31. Wennberg RP, Ahlfors CE, Rasmussen LF. The pathochemistry of kernicterus. Early Hum Dev 1979;3:353-72.
32. Mollison PL, Cutbush M. Haemolytic disease of the newborn. In: Gardner K, editor. Recent Advances in Pediatrics. London: J.A. Churchill Ltd.;1954.pp. 10-32.
33. Bhutani VK, Johnson LH. Jaundice technologies: prediction of hyperbilirubinaemia in term and near-term newborns. J Perinatol 2001;21 (Suppl. 1):S76-S82.
34. Ostrow JD, Mukerjee P, Tiribelli C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 1994;35:1715-37.
35. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999;274:10852-62.
36. Schutta HS, Johnson LH. Bilirubin encephalopathy in the Gunn rat: a fine structure study of the cerebellar cortex. J Neuropathol Exp Neurol 1967;26:377-96.
37. Malamud N. Pathogenesis of kernicterus in the light of its sequelae. In: Swinyard CA, editor. Kernicterus and its Importance in Cerebral Palsy. Springfield, IL: Charles C. Thomas;1961.pp. 230-46.
38. Ahdab-Barmada M, Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropathol Exp Neurol 1984;43:45-56.
39. Martich-Kriss V, Kollias SS, Ball WS Jr. MR findings in kernicterus. Am J Neuroradiol 1995;16 (4 Suppl.):819-21.
40. Yamamura H, Takagishi Y. Cerebellar hypoplasia in the hyperbilirubinemic Gunn rat: morphological aspects. Nagoya J Med Sci 1993;55:11-21.
41. Sawasaki Y, Yamada N, Nakajima H. Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinaemia. J Neurochem 1976;27:577-83.
42. Conlee JW, Shapiro SM. Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis. Acta Neuropathol (Berl) 1997;93:450-60.
43. Jew JY, Sandquist D. CNS changes in hyperbilirubinaemia. Functional implications. Arch Neurol 1979;36:149-54.
44. Ostrow JD, Tiribelli C. Editorial: New concepts in bilirubin neurotoxicity and the need for studies at clinically relevant bilirubin concentrations. J Hepatol 2001;34:467-70.
45. Ostrow JD, Pascolo L, Tiribelli C. Editorial: Mechanisms of bilirubin neurotoxicity. Hepatology 2002;35:1277-80.
46. Ostrow JD, Pascolo L, Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003;54:98-104.
47. Hahm JS, Ostrow JD, Mukerjee P, Celic L. Ionization and self association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility. J Lipid Res 1992;33:1123-37.
48. Cestaro B, Cervato G, Ferrari S, Di Silvestro G, Monti D, Manitto P. Interaction of bilirubin with small unilamellar vesicles of dipalmitoylphosphatidylcholine. Ital J Biochem 1983;32:318-29.
49. Zucker SD, Goessling W, Bootle EJ, Sterritt C. Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching. J Lipid Res 2001;42:1377-88.
50. Chuniaud L, Dessante M, Chantoux F, Blondeau JP, Francon J, Trivin F. Cytotoxicity of bilirubin for human fibroblasts and rat astrocytes in culture. Effect of the ratio of bilirubin to serum albumin. Clin Chim Acta 1996;256:103-14.
51. Silva RFM, Mata LR, Gulbenkian S, Brito A, Tiribelli C, Brites D. Inhibition of glutamate uptake by unconjugated bilirubin in cultured rat astrocytes: Role of concentration and pH. Biochem Biophys Res Commun 1999;265:67-72.
52. Schiff D, Chan G, Poznansky MJ. Bilirubin toxicity in neural cell lines N115 and NBR10A. Pediatr Res 1985;19:908-11.
53. Grojean S, Koziel V, Vert P, Daval JL. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 2000;166:334-41.
54. Silva RFM, Rodrigues CMP, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 2001;34:402-8.
55. Rodrigues CMP, Sola S, Brites D. Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 2002;35:1186-95.
56. 14C between blood, cerebrospinal fluid, and brain tissue. Am J Physiol 1971;221:1264-70.
57. Gunn CK. Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 1938;29:137-9.
58. Johnson LH, Sarmiento F, Blanc WA, Day R. Kernicterus in rats with an inherited deficiency of glucuronyl transferase. Am J Dis Child 1959;97:591-608.
59. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RPJ, Roy Chowdhury J et al. Bilirubin-UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960-4.
60. Strebel L, Odell GB. Bilirubin uridine diphosphoglucuronyltransferase in rat liver microsomes. genetic variation and maturation. Pediatr Res 1971;5:548-59.
61. Schutta HS, Johnson LH. Clinical signs and morphologic abnormalities in Gunn rats treated with sulfadimethoxine. J Pediatr 1969;75:1070-9.
62. Swenson RM, Jew JY. Learning deficits and brain monoamines in rats with congenital hyperbilirubinaemia. Exp Neurol 1982;76:447-56.
63. Shapiro SM, Hecox KE. Development of brainstem auditory evoked potentials in heterozygous and homozygous jaundiced Gunn rats. Brain Res 1988;469:147-57.
64. Shapiro SM. Acute brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfonamide. Pediatr Res 1988;23:306-10.
65. Shapiro SM, Conlee JW. Brainstem auditory evoked potentials correlate with morphological changes in Gunn rat pups. Hear Res 1991;57:16-22.
66. Conlee JW, Shapiro SM. Morphological changes in the cochlear nucleus and nucleus of the trapezoid body in Gunn rat pups. Hear Res 1991;57:23-30.
67. 14C into the central nervous system. J Clin Invest 1966;45:678-89.
68. Odell GB. The distribution and toxicity of bilirubin. E. Mead Johnson address 1969. Pediatrics 1970;46:16-24.
69. Rose AL, Wisniewski H. Acute bilirubin encephalopathy induced with sulfadimethoxine in Gunn rats. J Neuropathol Exp Neurol 1979;38:152-64.
70. 13C NMR spectroscopy. J Biol Chem 1996;271:2397-105.
71. a determinations. BMC Biochem 2002;3:17.
72. Carey MC, Spivak W. Physical chemistry of bile pigments and porphyrins with particular reference to bile. In: Ostrow JD, editor. Bile Pigments and Jaundice; Molecular, Metabolic and Medical Aspects. New York: Marcel Dekker;1986.pp. 81-132.
73. Tipping E, Ketterer B, Christodoulides L. Binding to egg phosphatidylcholine of some organic anions (bromsulphophthalein, oestrone sulphate, haem and bilirubin) that bind to ligandin and aminoazo-dye binding protein A. Biochem J 1979;180:327-37.
74. Zucker SD, Goessling W. Mechanism of hepatocellular uptake of albumin-bound bilirubin. Biochim Biophys Acta 2000;1463:197-208.
75. Siam M, Blaha G, Lehner H. Maximum binding capacity of serum albumin for bilirubin is one, as revealed by circular dichroism. J Chem Soc Perkin Trans II 1998:853-6.
76. Mediavilla MG, Pascolo L, Rodriguez JV, Guibert EE, Ostrow JD, Tiribelli C. Uptake of [(3) H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration. FEBS Lett 1999;463:143-5.
77. Ahlfors CE. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 2000;279:130-5.
78. Weisiger RA, Ostrow JD, Koehler RK, Webster CC, Mukerjee P, Pascolo L et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem 2001;276:29953-60.
79. Jori G, Reddi E, Rubaltelli FF. Structural and functional differences between fetal and adult serum albumin. Intl J Pept Protein Res 1988;31:17-21.
80. Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991;80:1119-27.
81. Goessling W, Zucker SD. Role of apolipoprotein D in the transport of bilirubin in plasma. Am J Physiol Gastrointest Liver Physiol 2000;279:G356-G365.
82. Takahashi M, Sugiyama K, Shumiya S, Nagase S. Penetration of bilirubin into the brain of albumin-deficient and jaundiced rats (AJR) and Nagase analbuminemic rats. J Biochem (Tokyo) 1984;96:1705-12.
83. Brodersen R. Aqueous solubility, albumin binding and tissue distribution of bilirubin. In: Ostrow JD, editor. Bile Pigments and Jaundice; Molecular, Metabolic and Medical Aspects. New York: Marcel Dekker;1986.pp. 157-81.
84. Bratlid D, Cashore WJ, Oh W. Effect of acidosis on bilirubin deposition in rat brain. Pediatrics 1984;73:431-4.
85. Ahlfors CE, Bennett SH, Shoemaker CT, Ellis WG, Davis SL, Wennberg RP et al. Changes in the auditory brainstem response associated with intravenous infusion ofunconjugated bilirubin into infant rhesus monkeys. Pediatr Res 1986;20:511-5.
86. Snyder SH, Barañano DE. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 2001;25:294-8.
87. Barañano DE, Rao M, Ferris CD, Snyder SH. From the Cover: Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002;99:16093-8.
88. Strazielle N, Ghersi-Egea JF. Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol 2000;59:561-74.
89. Berman LB, Lapham LW, Pastore E. Jaundice and xanthochromia of the spinal fluid. J Lab Clin Med 1944;44:273-9.
90. Amatuzio DS, Weber LJ, Nesbitt S. Bilirubin and protein in the cerebrospinal fluid of jaundiced patients with severe liver disease with and without hepatic coma. J Lab Clin Med 1953;41:615-8.
91. Saunders NR, Dziegielewska KM. Transport in the developing brain. In: Pardridge WM, editor. Introduction to the Blood-Brain Barrier; Methodology, Biology and Pathology. Cambridge: UK Cambridge University Press;1998. pp. 277-89.
92. Wood JH. Neurobiology of Cerebrospinal Fluid. New York: Plenum Press;1980.
93. Johanson CE. Arachnoid membrane, subarachnoid CSF and pia-glia. In: Pardridge WM, editor. Introduction to the Blood-Brain Barrier; Methodology, Biology and Pathology. Cambridge UK: Cambridge University Press;1998. pp. 259-69.
94. Ghersi-Egea JF, Strazielle N. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 2001;52:83-8.
95. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989;86:695-8.
96. Borst P, Oude Elferink R. Mammalian abc transporters in health and disease. Annu Rev Biochem 2002;71:537-92.
97. Decleves X, Regina A, Laplanche JL, Roux F, Boval B, Launay JM et al. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J Neurosci Res 2000;60:594-601.
98. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal- fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999;96:3900-5.
99. Regina A, Koman A, Piciorti M, El Hafny B, Center MS, Bergmann R et al. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998;71:705-15.
100. Hirrlinger J, Konig J, Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 2002;82:716-9.
101. Borst P, Evers R, Kool M, Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta 1999;1461:347-57.
102. Wijnholds J, de Lange EC, Scheffer GL, van den Berg DJ, Mol CA, van der Valk MA et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000;105:279-85.
103. Kusuhara H, Suzuki H, Naito M, Tsuruo T, Sugiyama Y. Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line. J Pharmacol Exp Ther 1998;285:1260-5.
104. Petrovic S, Pascolo L, Gallo R, Cupelli F, Ostrow JD, Goffeau A et al. The products of YCF1 and YLL015w (BPT1) cooperate for the ATP-dependent vacuolar transport of unconjugated bilirubin in Saccharomyces cerevisiae. Yeast 2000;16:561-71.
105. Seetharaman S, Barrand MA, Maskell L, Scheper RJ. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J Neurochem 1998;70:1151-9.
106. Golden PL, Pardridge WM. Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. Cell Mol Neurobiol 2000;20:165-81.
107. Gosland MP, Brophy NA, Duran GE, Yahanda AM, Adler KM, Hardy RI et al. Bilirubin: a physiological substrate for the multidrug transporter. (Abstract) Proc Am Assn Cancer Res 1991;32:426.
108. Watchko JF, Daood MJ, Hansen TWR. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 1998;44:763-6.
109. Watchko JF, Ziegler J, Daood MJ, Balkundi D. Inhibition of human MDR1 P-glycoprotein increases bilirubin-induced cell apoptosis in vitro. (Abstract) Pediatr Res 2003;53:400A.
110. Strazielle N, Ghersi-Egea JF. Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 1999;19:6275-89.
111. Gao B, Meier PJ. Organic anion transport across the choroid plexus. Microsc Res Tech 2001;52:60-4.
112. Nishino J, Suzuki H, Sugiyama D, Kitazawa T, Ito K, Hanano M et al. Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. J Pharmacol Exp Ther 1999;290:289-94.
113. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001;276:9626-30.
114. Briz O, Serrano MA, Macias RI, Gonzalez-Gallego J, Marin JJ. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J 2003;371:897-905.
115. Wang P, Kim RB, Roy Chowdhury R, Wolkoff AW. The Human Organic Anion Transport Protein SLC21A6 Is Not Sufficient for Bilirubin Transport. J Biol Chem 2003;278:20695-9.
116. Kapitulnik J, Gonzalez FJ. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Molec Pharmacol 1993;43:722-5.
117. Morse DC, Stein AP, Thomas PE, Lowndes HE. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol Appl Pharmacol 1998;152:232-9.
118. Brodersen R, Bartels P. Enzymatic oxidation of bilirubin. Eur J Biochem 1969;10:468-73.
119. Hansen TWR, Allen JW. Bilirubin-oxidizing activity in rat brain. Biol Neonate 1996;70:289-95.
120. Suleman FG, Ghersi-Egea JF, Leininger-Muller B, Minn A. Uridine diphosphate-glucuronosyltransferase activities in rat brain microsomes. Neurosci Lett 1993;161:219-22.
121. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-59.
122. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev 1999;13:239-52.
123. Zucker SD, Gössling W, Ransil BJ, Gollan JL. Influence of glutathione S-transferase B (ligandin) on the intermembrane transfer of bilirubin - implications for the intracellular transport of nonsubstrate ligands in hepatocytes. J Clin Invest 1995;98:1927-35.
124. Mannervik B. The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 1985;57:357-417.
125. Sugiyama Y, Sugimoto M, Stolz A, Kaplowitz N. A comparison of the binding affinities of five forms of rat glutathione-S-transferases for bilirubin, sulfobromophthalein and hematin. Biochem Pharmacol 1984;33:3511-3.
126. Johnson JA, el Barbary A, Kornguth SE, Brugge JF, Siegel FL. Glutathione S-transferase isoenzymes in rat brain neurons and glia. J Neurosci 1993;13:2013-23.
127. Johnson JA, Hayward JJ, Kornguth SE, Siegel FL. Effects of hyperbilirubinaemia on glutathione S-transferase isoenzymes in cerebellar cortex of the Gunn rat. Biochem J 1993;291:453-61.
128. Abramovitz M, Homma H, Ishigaki S, Tansey F, Gammer W, Listowsky I. Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 1988;50:50-7.
129. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, Davoodi J et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 2002;22:2035-43.
130. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996;379:349-53.
131. Simons M, Beinroth S, Gleichmann M, Liston P, Korneluk RG, MacKenzie AE et al. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J Neurochem 1999;72:292-301.
132. Xu DG, Crocker SJ, Doucet JP, St Jean M, Tamai K, Hakim AM et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 1997;3:997-1004.
133. Yaraghi Z, Korneluk RG, MacKenzie A. Cloning and characterization of the multiple murine homologues of NAIP (neuronal apoptosis inhibitory protein). Genomics 1998;51:107-13.
134. Pari G, Berrada F, Verge G, Karpati G, Nalbantoglu J. Immunolocalization of NAIP in the human brain and spinal cord. Neuroreport 2000;11:9-14.
135. Xu DG, Korneluk RG, Tamai K, Wigle N, Hakim A, MacKenzie A et al. Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system. J Comp Neurol 1997;382:247-59.
136. Ingram-Crooks J, Holcik M, Drmanic S, MacKenzie AE. Distinct expression of neuronal apoptosis inhibitory protein (NAIP) during murine development. Neuroreport 2002;13:397-402.
137. Odell GB, Storey GNB, Rosenberg LA. Studies in kernicterus. III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr 1970;76:12-21.
138. Johnson LH, Boggs TR Jr. Bilirubin-dependent brain damage; Incidence and indication for treatment. In: Odell GB, Schaffer R, Simopoulos AP, editors. Phototherapy in the Newborn; an Overview. Washington D.C.: National Academy of Sciences; 1974.pp. 122-49.
139. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642-7.
140. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin and auditory brainstem responses. Pediatrics 1994;93:50-3.
141. Ahlfors CE, Shapiro SM. Auditory brainstem response and unbound bilirubin in jaundiced (jj) Gunn rat pups. Biol Neonate 2001;80:158-62.
142. Amin SB, Ahlfors C, Orlando MS, Dalzell LE, Merle KS, Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 2001;107:664-70.
143. Shapiro SM. Reversible brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfonamide. Pediatr Res 1993;34:629-33.
144. Wennberg RP, Ahlfors CE, Bickers R, McMurtry CA, Shetter JL. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinaemia: improvement with exchange transfusion. J Pediatr 1982;100:624-6.
145. Nwaesei CG, Van Aerde J, Boyden M, Perlman M. Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics 1984;74:800-3.
146. Bratlid D. Criteria for treatment of neonatal jaundice. J Perinatol 2001;21 (Suppl. 1):S88-S92.
147. Mathieu MC, Lapierre I, Brault K, Raymond M. Aromatic hydrocarbon receptor (AhR) AhR nuclear translocator-and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a) pyrene in hepatoma cells. J Biol Chem 2001;276:4819-27.
148. Jorritsma U, Schrader E, Klaunick G, Kapitulnik J, Hirsch-Ernst KI, Kahl GF et al. Monitoring of cytochrome P-450 1A activity by determination of the urinary pattern of caffeine metabolites in Wistar and hyperbilirubinemic Gunn rats. Toxicology 2000;144:229-36.
149. Hervieux J. De L'ictere des nouveau-nes. Paris: Thesis, University of Paris;1847.